<DOC>
	<DOCNO>NCT03060044</DOCNO>
	<brief_summary>Pharmacokinetic study compare Salmeterol/fluticasone Easyhaler product Seretide Diskus 50/500 Âµg/inhalation ; randomise , open , single centre , single dose , crossover study healthy subject</brief_summary>
	<brief_title>Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Seretide Diskus</brief_title>
	<detailed_description />
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Charcoal</mesh_term>
	<criteria>write informed consent obtain good general health ascertain detailed medical history , laboratory physical examination evidence clinically significant cardiovascular , renal , hepatic , hematological , GI , pulmonary , metabolicendocrine , neurological psychiatric disease within previous 2 year condition require concomitant treatment ( include vitamin herbal product ) likely need concomitant treatment study . exception paracetamol ibuprofen occasional pain allow know hypersensitivity active substance ( ) excipient ( lactose , contain small amount milk protein ) drug pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>